HealthLynked Corp.
HLYK · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $389 | $592 | $774 | $619 |
| % Growth | -34.4% | -23.5% | 25.1% | – |
| Cost of Goods Sold | $9 | $16 | $18 | $9 |
| Gross Profit | $379 | $576 | $756 | $610 |
| % Margin | 97.6% | 97.3% | 97.7% | 98.5% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $737 | $1,032 | $995 |
| SG&A Expenses | $501 | $737 | $629 | $995 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $408 | $275 | $744 | $364 |
| Operating Expenses | $909 | $1,012 | $1,374 | $1,358 |
| Operating Income | -$530 | -$435 | -$617 | -$749 |
| % Margin | -136.3% | -73.5% | -79.7% | -121% |
| Other Income/Exp. Net | -$322 | -$266 | -$434 | -$481 |
| Pre-Tax Income | -$852 | -$701 | -$1,051 | -$1,230 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$852 | -$701 | -$1,051 | -$1,230 |
| % Margin | -219.2% | -118.3% | -135.7% | -198.8% |
| EPS | -0.3 | -0.25 | -0.37 | -0.44 |
| % Growth | -20% | 32.4% | 15.9% | – |
| EPS Diluted | -0.3 | -0.25 | -0.37 | -0.44 |
| Weighted Avg Shares Out | 2,832 | 2,819 | 2,819 | 2,815 |
| Weighted Avg Shares Out Dil | 2,832 | 2,819 | 2,819 | 2,815 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | -$51 | $293 | $67 | $584 |
| Depreciation & Amortization | $20 | $27 | $28 | $28 |
| EBITDA | -$509 | -$381 | -$589 | -$618 |
| % Margin | -131.1% | -64.3% | -76.1% | -99.8% |